Private Equity Investing in Longevity and Hormones with Tara Mandal (Partner & COO of PEAL Capital)
Description
This week, our guest is Tara Mandal, Partner and COO of PEAL Capital Partners. Before joining PEAL, Tara had an illustrious career at J.P. Morgan, where she crossed paths with Paul in Geneva. We’re also joined by Allison Stuckless as co-host. Allison, also a former J.P. Morgan alumna, is now a UK- based traditional search fund entrepreneur.
PEAL Capital Partners is a female-founded, European based, lower mid-market private equity firm specializing in control investments within the rapidly growing sector of Longevity and Hormones.
During the episode we cover why the PEAL team decided to pursue this investing niche, why they think the addressable market is underestimated, the team's 3 fund playbook, current acquisitions, and how they partners with operators/doctors to drive deal flow.
This is a fascinating episode that covers a trending yet very niche investing topic. We hope you enjoy it as much as we did!
To register for the practical IDS session with Rob Liddiard (Paul's EOS implementer), follow this link: https://us06web.zoom.us/meeting/register/tZ0rd-CprDkuH9YwmWrSyBm4-D7mDrybyfky
---
Also, we still have 3 seats available for the early access, discounted price, for the next Buy and Build...
Published 10/28/24
Still 3 seats available for the early access, discounted price, for the next Buy and Build Accelerator. https://www.buyandbuildaccelerator.com/
----------------------------
In this episode of Buy and Build, we chat with Toby Henry, founder of Full Circle Capital, who shares his rapid...
Published 10/16/24